within Pharmacolibrary.Drugs.ATC.A;

model A03BA01_1
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 2.25e-05,
    adminDuration  = 600,
    adminMass      = 2.0 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0017,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0011333333333333334,
    Tlag           = 600,            
    Vdp             = 0.0007,
    k12             = 1.1,
    k21             = 1.1
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A03BA01_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Atropine is an antimuscarinic (anticholinergic) drug that blocks the actions of acetylcholine at muscarinic receptors. It is primarily used to treat bradycardia (slow heart rate), as a premedication for anesthesia to reduce salivation, to reverse cholinergic poisoning (from organophosphates or nerve agents), and to dilate pupils in ophthalmology. Atropine is widely approved and used today in various clinical settings.</p><h4>Pharmacokinetics</h4><p>Healthy adults after oral administration, single dose.</p><h4>References</h4><ol><li><p>Parrot, M, et al., &amp; Yellepeddi, V (2024). Clinical pharmacokinetics of atropine oral gel formulation in healthy volunteers. <i>Clinical and translational science</i> 17(3) e13753–None. DOI:<a href=\"https://doi.org/10.1111/cts.13753\">10.1111/cts.13753</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38465519/\">https://pubmed.ncbi.nlm.nih.gov/38465519</a></p></li><li><p>Mubaslat, O, et al., &amp; Lambert, T (2022). Pharmacokinetics and Effects on Saliva Flow of Sublingual and Oral Atropine in Clozapine-Treated and Healthy Adults: An Interventional Cross-Over Study. <i>Psychiatry and clinical psychopharmacology</i> 32(1) 17–27. DOI:<a href=\"https://doi.org/10.5152/pcp.2022.21221\">10.5152/pcp.2022.21221</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38764898/\">https://pubmed.ncbi.nlm.nih.gov/38764898</a></p></li><li><p> (2024). Correction to &quot;Clinical pharmacokinetics of atropine oral gel formulation in healthy volunteers&quot;. <i>Clinical and translational science</i> 17(5) e13817–None. DOI:<a href=\"https://doi.org/10.1111/cts.13817\">10.1111/cts.13817</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38708579/\">https://pubmed.ncbi.nlm.nih.gov/38708579</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A03BA01_1;
